A bispecific approach to improving CAR T cells in AML
- PMID: 32135017
- DOI: 10.1182/blood.2020004791
A bispecific approach to improving CAR T cells in AML
Comment on
-
Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.Blood. 2020 Mar 5;135(10):713-723. doi: 10.1182/blood.2019002779. Blood. 2020. PMID: 31951650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical